| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
CalciMedica, Inc.
13D/A
Amendment 1
CALC · 38942Q202
|
10.0% |
8/21/2026
Event 8/19/2026
|
|||
| Bering Partners II GP, L.L.C. | 10.0% | ||||
| Bering Partners II, L.P. | 10.0% | ||||
| Evgeny Zaytsev | 10.0% | ||||
| Philip M Sawyer | 10.0% | ||||
|
CalciMedica, Inc.
13D
CALC · 38942Q202
|
6.9% |
7/2/2026
Event 6/25/2026
|
|||
| Bering Partners II GP, L.L.C. | 6.9% | ||||
| Bering Partners II, L.P. | 6.9% | ||||
| Evgeny Zaytsev | 6.9% | ||||
| Philip M Sawyer | 6.9% | ||||
|
CalciMedica, Inc.
13G
CALC · 38942Q202
|
5.8% |
10/29/2025
Event 1/23/2024
|
|||
| Bering Partners II, L.P. ("Bering II") | 5.8% | ||||
| Bering Partners II GP, L.L.C. ("Bering II GP") | 5.8% | ||||
| Evgeny Zaytsev ("Zaytsev") | 5.8% | ||||
| Philip Sawyer ("Sawyer") | 5.8% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.